人抗菌肽在眼表防御中的作用
眼表依赖透明角膜与中心凹聚焦维持视力,其暴露位置使其易受微生物感染。角膜内生抗菌肽(AMP)是抵御病毒、细菌、真菌和寄生虫的关键防御分子,部分兼具信号分子、免疫调节、抗肿瘤、影响血管化与伤口愈合等非杀菌功能。多种病原体经Toll样受体(TLR)诱导特定AMP表达,非TLR途径亦可被L-异亮氨酸、丁酸钠、维生素D3等分子诱导。鉴于微生物耐药上升与新抗生素研发缓慢,寻找单用或联合有效的AMP以减少对单一抗生素依赖被视为理想方向。
要点
- 角膜内生抗菌肽(AMP)是小分子阳离子肽,对病毒、细菌、真菌和寄生虫有广泛活性。
- 多种眼感染病原体(结核分枝杆菌、疱疹病毒、棘阿米巴等)经TLR激活诱导特定AMP表达。
- AMP具信号分子、免疫调节、抗肿瘤、影响血管化与伤口愈合等非杀菌功能。
核心结论
- 鉴于微生物耐药上升、新抗生素研发缓慢及发展中国家患者获取有效抗生素受限,理想方案是找到单用或相互联合或与其他抗菌蛋白联合有效的AMP,以尽可能减少对单一抗生素的依赖。
研究设计与样本
- 本文为综述,围绕人抗菌肽在眼表防御中的作用进行总结,原文未报告系统检索范围。
主要发现
- 角膜内生AMP为小分子量阳离子肽,对病毒、细菌、真菌和寄生虫有广泛活性,RNases与S100A家族蛋白亦归入此类。
- 多种AMP可协同作用,使多种AMP在低表达水平下仍能高效发挥作用。
- AMP兼具信号分子、免疫调节、抗肿瘤活性及影响血管化与伤口愈合等非杀菌功能。
- 不同TLR参与特定AMP的优先诱导;结核分枝杆菌、疱疹病毒、真菌及棘阿米巴等眼感染病原体可经TLR激活诱导特定AMP。
- 非TLR介导的AMP表达诱导亦可发生,已识别L-异亮氨酸、丁酸钠、维生素D3、苯丁酸钠、血管活性肠肽和etinostat等分子。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sight depends on the passage of light through the transparent cornea and being focused on the fovea. Its exposed position renders it vulnerable to microbial infection. The cornea has developed a wide array of defense mechanisms against infection, of which endogenous antimicrobial peptides (AMPs) are key. AMPs are essentially small molecular weight cationic peptides with a wide range of activity against virus, bacteria, fungi and parasites. Some proteins such as RNases and S100As are also included in this group. Several AMPs act synergistically allowing low expression of multiple AMPs to act efficiently. AMPs also have a range of non-microbicidal functions and serve as signaling molecules, immunomodulators; show anti-tumour activity, and influence vascularization and wound healing. Different toll-like receptors (TLR) have been implicated in the preferential induction of specific AMPs. A range of bacteria, including mycobacteria tuberculosis, viruses including herpes virus, fungi and parasites including acanthamoeba, that cause ocular infections have been shown to induce specific AMPs via TLR activation. Non-TLR mediated induction of AMP expression can occur and several molecules such as L-isoleucine, sodium butyrate, vitamin D3, phenylbutyrate, vasoactive intestinal peptide, and etinostat have been identified in this regard. Given the rising microbe resistance to antibiotics, the slow rate of development of new antibiotics and the limited access to effective antibiotics by patients living in the developing world, an ideal solution would be to find AMPs that are effective singly or in combination with each other or other antimicrobial proteins to reduce, if possible eliminate reliance on antibiotics alone.
引用
- Mohammed I, Said DG, Dua HS, et al. Human antimicrobial peptides in ocular surface defense. Prog Retin Eye Res. 2017. PMID: 28587935. doi:10.1016/j.preteyeres.2017.03.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。